Companies/Atlas Energy Corp.

Company profile

Atlas Energy Corp.

OTC: CANSF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Calgary, ABReports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

54D

FH 73DQ —GM 4SS 39

v0.1 · 45/100 weight · provisional

↑ balance-sheet leverage, Altman-Z · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$1.9M

Employees

Market cap

$43.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$1.9M-2.6M CAD2025

Operating income-$2.0M-2.8M CAD2025

Total assets$20.2M27.6M CAD2025

Liabilities$279.9k383.7k CAD2025

Equity$19.9M27.3M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$13.1k

FY18

$3.5k

FY19

$7.5k

FY20

$106.1k

FY21

$631.0k

FY22

$868.4k

FY23

$3.4M

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Atlas Energy Corp. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

BioXcel Therapeutics, Inc.27D Planet 13 Holdings Inc.45D PetMed Express, Inc.43D Estrella Immunopharma, Inc.——

Key facts

CEOMark Alan Hodgson

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersCalgary, AB

ExchangeOTC: CANSF

Employees19

IPO date2021-01-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.